“Functional Equivalence” Upheld In Court; Amgen Cannot Challenge Decision

The Centers for Medicare & Medicaid Services has the authority to enforce its position that Amgen's Aranesp is "functionally equivalent" to J&J's Procrit for reimbursement purposes, a D.C. federal appeals court ruled